241 / 1578
/
Study characteristic published in
2015
Median age at diagnosis
(SEER)
Tumor entity Study question
Median age Maximum age
Breast
RT of mammaria interna
54 years 75 years
61 years
Breast
RT of mammaria interna
54 years 84 years
61 years
NSCLC
Dose escalation
Cetuximab
64 years 83 years
70 years
Rectal
Adjuvant CT after
neoadjuvent RCHT
62 years 68 years
68 years
Prostate
Duration AHT
72 years 85 years
66 years
Prostate
Hypofractionation of
RT
71 years 75 years
66 years
Recent randomized studies in
Radation Oncology
Ø
Lack of evidence covering elderly patients
ESTRO SBRT COURSE 2017 - Matthias Guckenberger
9
07.09.17
/
Overall population SEER > 65 years
Netherlands >75a
Surgery
RT
BSC
Surgery
RT
BSC
Surgery
RT
BSC
Raz Chest 2007
Shirvani IJROBP 2012 Haasbeek Ann Oncol 2012
11%
13%
29%
Treatment given to patients with curable
stage I NSCLC
Ø
1/3 of all patients >75 old remain untreated
ESTRO SBRT COURSE 2017 - Matthias Guckenberger
10
07.09.17